Acquired MET amplification in non-small cell lung cancer is...

  • Main
  • 2020 / 11
  • Acquired MET amplification in non-small cell lung cancer is...
Experimental and Molecular Pathology 2020 / 11

Acquired MET amplification in non-small cell lung cancer is highly associated with the exposure of EGFR inhibitors and may not affect patients' outcome

Yin, Wei, Liu, Wei, Guo, Ming, Tang, Zhenya, Toruner, Gokce, Robinson, Melissa, Cheng, Joanne, Hu, Shimin, Medeiros, L. Jeffrey, Tang, Guilin
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Journal:
Experimental and Molecular Pathology
DOI:
10.1016/j.yexmp.2020.104572
Date:
November, 2020
File:
PDF, 942 KB
2020
Conversion to is in progress
Conversion to is failed